Cellino
Cellino Bio is dedicated to transforming treatment experiences for degenerative diseases through personalized regenerative medicine. Utilizing proprietary AI-driven optical bioprocesses and advanced biomanufacturing technologies, the company aims to make patient-specific cell, tissue, and organ replacements widely accessible. Their mission is to unlock the power of personalized regenerative medicine to address challenging diseases and improve patient outcomes.
Industries
Nr. of Employees
small (1-50)
Cellino
Patents
Products
Modular cassette-based biomanufacturing platform
A compact, modular manufacturing system that integrates imaging, optics-based manipulation, automation, and disposable cassettes to produce patient-specific cell products at distributed sites or centralized foundries.
Modular cassette-based biomanufacturing platform
A compact, modular manufacturing system that integrates imaging, optics-based manipulation, automation, and disposable cassettes to produce patient-specific cell products at distributed sites or centralized foundries.
Services
Derivation of induced pluripotent stem cells from patient samples and differentiation into specific cell types within a regulated foundry workflow for clinical use.
Collaborative programs with industry partners to develop and integrate platform manufacturing capabilities for autologous cell therapy programs.
Derivation of induced pluripotent stem cells from patient samples and differentiation into specific cell types within a regulated foundry workflow for clinical use.
Collaborative programs with industry partners to develop and integrate platform manufacturing capabilities for autologous cell therapy programs.
Expertise Areas
- Personalized regenerative medicine
- Autologous iPSC manufacturing
- Bioprocess automation and foundry operations
- Image-guided cell processing
Key Technologies
- Deep learning / AI for process control
- In silico simulation / digital twin
- Laser-based cell manipulation
- Image-guided optical bioprocessing